What is the Impact Factor of Bladder Cancer?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Bladder Cancer is 2.20, ranking in quartile Q3 of Web of Science (SCIE).

Is Bladder Cancer indexed in Web of Science or Scopus?

Yes, Bladder Cancer is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.595 (Q2) and an H-index of 33.

Who publishes Bladder Cancer and what is the Article Processing Charge (APC)?

Bladder Cancer is published by IOS Press. The estimated Article Processing Charge (APC) is approximately $2,892 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Bladder Cancer?

The official ISO-4 abbreviation of Bladder Cancer is "BLADDER CANCER" with common acronym "blc". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #9,947Hybrid

Bladder Cancer

Acronym:blc

•

Abbreviation (ISO):BLADDER CANCER

•

Identifier (ISSN):2352-3727(Print)/2352-3735(Online)

•

Publisher:IOS Press

Submission Portal Compare

Clarivate IF (2026)

2.2↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Bladder Cancer

WoS Q3

Annual Impact Factor Metric

Current (2026):2.2

Scopus SJR & RankScopus Q2

0.595

#9,947

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

33 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate10%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

39articles/year

88.46% Gold OA•76.67% Original Research

Aims & Scope

Bladder Cancer is an international multidisciplinary journal to facilitate progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal publishes research reports, reviews, short communications, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that expedites our fundamental understanding and improves treatment of tumors of the bladder and upper urinary tract.

Topics Covered (Recognized by AI)

MedicineInternal MedicineBiologyGeneticsOncology & Cancer ResearchPathologySurgeryOncologyMathematicsChemistryStatisticsBiochemistryImmunology

Primary Research Areas

Medicine Urology

NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank228/333

IndexSCIE

JCRSCIE2026

UROLOGY & NEPHROLOGY

Rank66/134

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank275/333

IndexSCIE

JCISCIE2026

UROLOGY & NEPHROLOGY

Rank107/134

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	228/333	Q3
UROLOGY & NEPHROLOGY	JCRSCIE	66/134	Q2
ONCOLOGY	JCISCIE	275/333	Q4
UROLOGY & NEPHROLOGY	JCISCIE	107/134	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.2

Articles / Year22

Total Citations3

2025

IF1.2

Articles / Year28

Total Citations66

2024

IF1

Articles / Year27

Total Citations99

2023

IF1.1

Articles / Year40

Total Citations109

2022

IF1.449

Articles / Year35

Total Citations152

Year	Impact Factor	Articles / Year	Total Citations
2026	2.2	22	3
2025	1.2	28	66
2024	1	27	99
2023	1.1	40	109
2022	1.449	35	152
2021	3.269	99	210
2020	2.778	67	470
2019	—	38	338
2018	—	55	1,219
2017	—	84	898
2016	—	52	1,501
2015	—	61	452

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,947Scopus Q2SCImago Profile

Scopus Coverage:2015-2024

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.595

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.14

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,892 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations133

3-Year Documents108

Citable Documents102

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate0.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

UrologyQ2

OncologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 10%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Bladder Cancer (acronym: blc, abbr: BLADDER CANCER, ISSN: 2352-3727) is a peer-reviewed international scholarly journal in the field of Medicine, published by IOS Press in Netherlands. The periodical holds a Journal Impact Factor (JIF) of 2.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.595 (Q2), an H-index of 33.

The journal enforces rigorous peer evaluation with an annual output of approximately 39 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,892 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.